Affinage

UBAP2L

Ubiquitin-associated protein 2-like · UniProt Q14157

Length
1087 aa
Mass
114.5 kDa
Annotated
2026-04-28
32 papers in source corpus 16 papers cited in narrative 16 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

UBAP2L is a ubiquitin-associated and RNA-binding scaffolding protein that functions as a master nucleator of cytoplasmic RNA granules, a regulator of mitotic progression, and a facilitator of nuclear pore complex assembly. In stress granule biology, UBAP2L acts upstream of G3BP1/2 to nucleate stress granules via its RGG motif (which recruits mRNPs and is regulated by PRMT1-mediated arginine methylation) and its DUF domain (which engages G3BP1/2 in a snoRNA-bridged complex); it also localizes to processing bodies through DDX6 binding and mediates SG–PB interactions (PMID:31956030, PMID:31114027, PMID:37059803, PMID:39007803). Beyond RNA granule biology, UBAP2L promotes UV-induced ubiquitylation and degradation of RNA polymerase II by recruiting the Elongin–Cul5 ubiquitin ligase as the human orthologue of yeast Def1, controls PLK1 localization and ubiquitin-mediated turnover during mitosis to ensure proper chromosome segregation, and scaffolds Y-complex assembly and sequential nucleoporin interactions (POM121, Nup153, FXR1) required for nuclear pore complex biogenesis (PMID:35633597, PMID:37039032, PMID:38652117). UBAP2L also resides in a BMI1-containing Polycomb subcomplex essential for long-term hematopoietic stem cell maintenance and interacts specifically with mTORC1 components mTOR and Raptor to sustain mTORC1 signaling (PMID:25185265, PMID:34171383).

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 2014 High

    Establishing that UBAP2L functions within the Polycomb pathway: UBAP2L was identified as a physical partner of BMI1 in a distinct PcG subcomplex, and BMI1 overexpression rescued UBAP2L-depleted hematopoietic stem cell defects, placing UBAP2L in chromatin-associated gene regulation independent of the canonical Ink4a/Arf-targeting complex.

    Evidence Reciprocal co-IP with mass spectrometry, genetic epistasis via BMI1 rescue, in vivo transplantation assays in mouse hematopoietic system

    PMID:25185265

    Open questions at the time
    • Biochemical function of UBAP2L within the BMI1 complex (e.g., ubiquitin ligase adaptor vs. reader) not defined
    • Genomic targets of the UBAP2L–BMI1 subcomplex not identified
    • Whether this function extends beyond hematopoietic stem cells is unknown
  2. 2019 High

    Defining the domain architecture and post-translational regulation of UBAP2L in stress granule nucleation: the RGG motif was shown to recruit mRNPs and SG components while the DUF domain mediated G3BP1/2 binding, and PRMT1-catalyzed asymmetric arginine dimethylation of the RGG motif was demonstrated to antagonize SG assembly by weakening UBAP2L–mRNP interactions.

    Evidence Domain deletions, co-IP, overexpression-driven SG assay, PRMT1 knockdown/overexpression, in vitro methylation assays

    PMID:31114027

    Open questions at the time
    • Whether PRMT1-mediated methylation is dynamically regulated during stress recovery is not resolved
    • Structure of the DUF–G3BP interface not determined
    • Specific RNA species bound by the RGG motif during SG formation not catalogued
  3. 2020 High

    Resolving the epistatic hierarchy of stress granule nucleation: super-resolution imaging revealed that UBAP2L forms distinct granule cores separate from G3BP1 cores, and genetic experiments established that UBAP2L can nucleate granules independently of G3BP1/2, placing it as the most upstream known SG nucleator.

    Evidence Super-resolution and expansion microscopy, siRNA knockdown of UBAP2L and G3BP1/2, multiple stress conditions in human cells

    PMID:31956030

    Open questions at the time
    • What triggers UBAP2L condensation upon stress is unknown
    • Whether UBAP2L undergoes liquid-liquid phase separation or forms solid-like assemblies not established
    • Relationship between UBAP2L cores and downstream SG maturation not fully defined
  4. 2021 Medium

    Linking UBAP2L to mTORC1 signaling: UBAP2L was identified as a specific interactor of mTOR and Raptor (but not Rictor), and its depletion reduced mTORC1 activity as measured by S6K phosphorylation.

    Evidence SILAC-based mTOR interactome, confirmatory co-IP, UBAP2L knockdown with mTORC1 readout

    PMID:34171383

    Open questions at the time
    • Single co-IP confirmation from one laboratory without reciprocal pull-down from UBAP2L side
    • Mechanism by which UBAP2L sustains mTORC1 activity (adaptor vs. localization vs. substrate presentation) unknown
    • Whether mTORC1 interaction is linked to or independent of SG biology not addressed
  5. 2022 High

    Identifying UBAP2L as the human functional orthologue of yeast Def1 in transcription-coupled DNA damage response: UBAP2L (and UBAP2) were shown to recruit the Elongin–Cul5 E3 ubiquitin ligase to promote UV-induced ubiquitylation and proteasomal degradation of RNA Pol II subunit RPB1.

    Evidence UV-irradiation, UBAP2/UBAP2L knockdown, co-IP with Elongin–Cul5, RPB1 ubiquitylation and degradation assays in human cells

    PMID:35633597

    Open questions at the time
    • Whether UBAP2L acts as a direct substrate adaptor or an allosteric activator of the Elongin–Cul5 complex not determined
    • Structural basis for Elongin–Cul5 recruitment by UBAP2L not resolved
    • Redundancy between UBAP2 and UBAP2L in this pathway not fully dissected
  6. 2023 High

    Revealing that snoRNAs bridge the UBAP2L–G3BP1 interaction: in vitro binding experiments demonstrated that snoRNAs are required for UBAP2L to associate with G3BP1, and snoRNA depletion suppressed SG formation, establishing an RNA-dependent mechanism for SG nucleation complex assembly.

    Evidence In vitro binding assays, RNA immunoprecipitation, snoRNA knockdown, proteomics and RNA-seq

    PMID:37059803

    Open questions at the time
    • Identity of the specific snoRNA species most critical for bridging not narrowed to individual candidates
    • Whether snoRNAs serve a structural vs. catalytic role in the complex is unknown
    • Whether snoRNA bridging is stress-regulated not tested
  7. 2023 High

    Establishing UBAP2L as a mitotic regulator of PLK1: UBAP2L depletion caused PLK1 stabilization and mislocalization to kinetochores, centrosomes, and spindle, leading to chromosome segregation errors; chemical PLK1 inhibition rescued these defects, and the C-terminal domain of UBAP2L was mapped as necessary for PLK1 regulation.

    Evidence siRNA knockdown, live-cell imaging, immunofluorescence, PLK1 inhibitor rescue, C-terminal domain deletion

    PMID:37039032

    Open questions at the time
    • Whether UBAP2L directly binds PLK1 or acts through an intermediate E3 ligase not resolved
    • The E3 ubiquitin ligase responsible for UBAP2L-dependent PLK1 ubiquitylation not identified
    • Whether the mitotic and SG functions of UBAP2L are mutually exclusive in cycling cells not tested
  8. 2024 High

    Defining UBAP2L as a scaffold for nuclear pore complex assembly: UBAP2L was shown to localize to nuclear pores, promote Y-complex formation and its recruitment to the nuclear envelope, and facilitate sequential interactions with POM121, Nup153, and FXR1, establishing it as a nucleoporin assembly factor at intact NEs.

    Evidence Co-IP, super-resolution microscopy, proximity ligation assay, siRNA knockdown, nuclear transport assays

    PMID:38652117

    Open questions at the time
    • Whether UBAP2L is a bona fide stoichiometric NPC component or a transient assembly factor not determined
    • Structural basis for UBAP2L interaction with the Y-complex not resolved
    • Interplay between NPC assembly and SG/PB functions of UBAP2L not examined
  9. 2024 High

    Expanding UBAP2L's granule biology to processing bodies: UBAP2L was shown to localize to PBs, bind DDX6 (a core PB component), promote PB biogenesis, and mediate physical SG–PB interactions including formation of hybrid granules.

    Evidence Immunofluorescence, live-cell imaging, UBAP2L knockdown with quantitative PB/SG analysis, co-IP with DDX6 and G3BP

    PMID:39007803

    Open questions at the time
    • Mechanism by which UBAP2L simultaneously engages SG and PB components at molecular level not defined
    • Functional consequence of SG–PB hybrid granules for mRNA fate not established
    • Whether PB localization requires the same domains (RGG, DUF) as SG localization not mapped
  10. 2024 High

    Revealing viral subversion of UBAP2L-dependent antiviral granule assembly: SARS-CoV-2 NSP3 was found to directly bind FMRP KH domains via a peptide motif that competes with a corresponding UBAP2L motif, disrupting FMRP–UBAP2L interaction and preventing FMRP incorporation into stress granules.

    Evidence In vitro binding/competition assay with synthetic peptides, mutant virus, domain mapping, infectivity assays

    PMID:38177924

    Open questions at the time
    • Whether other viral proteins similarly target the UBAP2L–FMRP axis not surveyed
    • Functional impact of FMRP exclusion from SGs on antiviral innate immunity not mechanistically dissected
    • Whether UBAP2L's NPC assembly role is also targeted during viral infection not examined
  11. 2025 Medium

    Connecting UBAP2L post-translational regulation to its stability and oncogenic functions: O-GlcNAcylation of UBAP2L was shown to antagonize TRIM37-mediated ubiquitylation, stabilizing the protein and promoting SG-dependent mRNA stabilization of Melk to activate PI3K signaling; separately, UBAP2L-nucleated SGs mediate chemoresistance by sequestering pro-apoptotic RACK1.

    Evidence IP-mass spectrometry for O-GlcNAcylation sites, TRIM37 ubiquitylation assays, RIP-seq, RACK1 co-localization/co-IP, in vivo xenograft models

    PMID:40804300 PMID:41029457

    Open questions at the time
    • Whether O-GlcNAcylation and arginine methylation cross-regulate each other on UBAP2L not tested
    • Direct evidence that RACK1 sequestration is the primary mechanism of chemoresistance (vs. other SG-sequestered factors) not established
    • TRIM37 as the primary E3 for UBAP2L turnover confirmed in only one cancer context

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key unresolved questions include: what upstream signal triggers UBAP2L condensation upon stress, the structural basis for its multi-domain scaffolding of diverse complexes (SGs, PBs, NPCs, Polycomb, mitotic spindle), whether its distinct cellular functions are temporally segregated across the cell cycle, and how its multiple post-translational modifications (methylation, O-GlcNAcylation, phosphorylation, ubiquitylation) are integrated to coordinate its pleiotropic roles.
  • No structural model of UBAP2L exists
  • How UBAP2L partitions between its nuclear (NPC, Polycomb) and cytoplasmic (SG, PB, mitotic) roles is unknown
  • Whether UBAP2L's diverse functions reflect independent modules or an integrated signaling hub is unresolved

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 5 GO:0003723 RNA binding 2 GO:0005198 structural molecule activity 2
Localization
GO:0005634 nucleus 3 GO:0005829 cytosol 3 GO:0005635 nuclear envelope 1 GO:0005856 cytoskeleton 1
Pathway
R-HSA-8953854 Metabolism of RNA 4 R-HSA-8953897 Cellular responses to stimuli 3 R-HSA-1640170 Cell Cycle 1 R-HSA-4839726 Chromatin organization 1 R-HSA-73894 DNA Repair 1 R-HSA-9609507 Protein localization 1
Complex memberships
BMI1-containing Polycomb subcomplexY-complex (NPC)mTORC1

Evidence

Reading pass · 16 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2020 UBAP2L forms distinct cores inside stress granules that occupy different domains from G3BP1, acts as an essential SG nucleator upstream of G3BP1/2, and is required for SG assembly under multiple stress conditions; UBAP2L can form granules independently of G3BP1/2 without interfering with stress-induced translational inhibition. Super-resolution and expansion microscopy, reverse genetics (knockdown), cell biology assays Current Biology High 31956030
2019 UBAP2L is required for both stress granule assembly and disassembly; its RGG motif mediates recruitment of SG components (mRNPs, RBPs, ribosomal subunits); its DUF domain mediates interaction with G3BP1/2; DUF deletion causes cytoplasmic-nuclear transport of UBAP2L and G3BP1/2. PRMT1 asymmetrically dimethylates UBAP2L at the RGG motif, and increased arginine methylation blocks while decreased methylation enhances UBAP2L interactions with SG components, modulating SG assembly. Co-immunoprecipitation, domain deletion/mutagenesis, overexpression-driven SG nucleation assay, PRMT1 knockdown/overexpression, methylation assays Cell Death and Differentiation High 31114027
2014 UBAP2L physically interacts with the Polycomb group protein BMI1 and is part of a BMI1-containing PcG subcomplex; BMI1 overexpression rescues the deleterious effects of UBAP2L depletion on long-term hematopoietic stem cell (LT-HSC) activity, placing UBAP2L in a BMI1-containing complex distinct from those regulating the Ink4a/Arf locus. Co-immunoprecipitation (BMI1 complex isolation), mass spectrometry, genetic epistasis (BMI1 overexpression rescue of UBAP2L knockdown), in vivo transplantation assay Blood High 25185265
2022 UBAP2L (and its paralogue UBAP2) are the human functional orthologues of yeast Def1, involved in UV-induced ubiquitylation and degradation of the largest RNA polymerase II subunit RPB1 through recruitment of the Elongin-Cul5 ubiquitin ligase. UV-irradiation assays, knockdown of UBAP2/UBAP2L, co-immunoprecipitation with Elongin-Cul5 complex, RPB1 ubiquitylation and degradation assays DNA Repair High 35633597
2023 UBAP2L controls both the localization and protein stability of PLK1 during mitosis; UBAP2L is a spindle-associated protein and its depletion leads to increased PLK1 protein levels, abnormal PLK1 accumulation at kinetochores, centrosomes and mitotic spindle, aberrant mitotic exit, and chromosome segregation defects. The C-terminal domain of UBAP2L mediates its effect on PLK1, and mitotic defects are rescued by PLK1 chemical inhibition, suggesting UBAP2L promotes ubiquitin-mediated PLK1 turnover. siRNA knockdown, live-cell imaging, immunofluorescence, PLK1 inhibitor rescue, domain mapping (C-terminal deletion), cell fractionation EMBO Reports High 37039032
2024 UBAP2L localizes to nuclear pores and is required for assembly and stability of nuclear pore complexes (NPCs) at the intact nuclear envelope; UBAP2L facilitates Y-complex formation, its localization to the NE, and promotes Y-complex interactions with POM121 and Nup153 in sequential order. UBAP2L also enables timely localization of FXR1 (cytoplasmic Nup transport factor) to the NE and its interaction with the Y-complex. Co-immunoprecipitation, super-resolution microscopy, proximity ligation assay, siRNA knockdown, nuclear transport assays, cell fractionation Journal of Cell Biology High 38652117
2024 UBAP2L also localizes to processing bodies (PBs) under certain conditions, contributes to PB biogenesis, mediates SG-PB interactions, and can nucleate hybrid granules containing both SG and PB components. UBAP2L binds both G3BP (SG protein) and DDX6 (PB protein). Immunofluorescence, live-cell imaging, UBAP2L knockdown with quantitative PB/SG analysis, co-immunoprecipitation with DDX6 and G3BP Journal of Cell Biology High 39007803
2023 UBAP2L forms a protein-RNA complex with G3BP1 bridged by small nucleolar RNAs (snoRNAs); in vitro binding analysis showed snoRNAs are required for UBAP2L association with G3BP1, and decreased snoRNA expression reduces UBAP2L-G3BP1 interaction and suppresses SG formation. Proteomics, RNA sequencing, in vitro binding assay, RNA immunoprecipitation, snoRNA knockdown Communications Biology High 37059803
2024 SARS-CoV-2 NSP3 binds directly to the two central KH domains of FMRPs (FMR1, FXR1, FXR2) via a unique peptide motif, and this interaction disrupts FMRP's interaction with UBAP2L through direct competition with a peptide motif in UBAP2L, thereby preventing FMRP incorporation into stress granules. Co-immunoprecipitation, in vitro binding/competition assay with peptides, mutant virus (NSP3 FMRP-binding mutants), domain mapping, infectivity assays EMBO Reports High 38177924
2021 UBAP2L (NICE-4) specifically binds to both mTOR and Raptor but not Rictor, indicating it specifically interacts with mTORC1 but not mTORC2, and is essential for basic mTORC1 activity. SILAC-based mTOR interactome screen, co-immunoprecipitation confirmation, UBAP2L knockdown with mTORC1 activity readout (S6K phosphorylation) Life Sciences Medium 34171383
2025 O-GlcNAcylation of UBAP2L promotes its protein stability by inhibiting TRIM37-mediated ubiquitination of UBAP2L; this modification regulates stress granule formation and enhances mRNA stability of Melk, activating PI3K signaling. Immunoprecipitation, mass spectrometry, modification-based proteomics, RNA-seq, RIP-seq, TRIM37 co-IP and ubiquitination assay Journal of Experimental & Clinical Cancer Research Medium 41029457
2023 PCK1 antagonizes CRC growth via inactivating UBAP2L phosphorylation at serine 454 and enhancing autophagy. Overexpression/knockdown of PCK1, phospho-specific mass spectrometry, autophagy assays Cancer Cell International Low 37062825
2017 UBAP2L knockdown inhibited hepatocellular carcinoma EMT by reducing SNAIL1 expression and its binding to the E-cadherin promoter via the SMAD2 signaling pathway. siRNA knockdown, wound healing/transwell invasion assay, promoter activity assay, Western blot for EMT markers and SMAD2 pathway components Cellular Physiology and Biochemistry Low 28334716
2021 UBAP2L activates Wnt/β-catenin signaling in gastric cancer cells, promoting nuclear β-catenin accumulation and expression of downstream targets (cyclin D1, AXIN-2, c-MYC); miR-148b-3p directly targets UBAP2L mRNA. siRNA knockdown, overexpression, luciferase reporter for β-catenin activity, constitutively active β-catenin rescue experiment, miRNA luciferase reporter assay Bioengineered Low 34823423
2022 UBAP2L promotes gastric cancer metastasis through the PI3K/AKT pathway, stimulating expression and nuclear accumulation of p65 (NF-κB) and promoting SP1 expression; identified by mass spectrometry interactome and pathway annotation. Mass spectrometry interactome, PI3K/AKT pathway inhibitor rescue, knockdown/overexpression, in vivo lung metastasis model Cell Death Discovery Low 35304439
2025 UBAP2L-nucleated stress granules mediate oxaliplatin resistance in gastric cancer by recruiting RACK1 (a pro-apoptotic protein) into SGs, sequestering it from executing apoptosis; UBAP2L transcription is upregulated by oxaliplatin-induced HSF1 phosphorylation via AKT. SG formation assays, RACK1 co-localization/co-IP, HSF1 inhibition, AKT inhibition, in vivo xenograft model, siRNA knockdown Communications Biology Medium 40804300

Source papers

Stage 0 corpus · 32 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2020 UBAP2L Forms Distinct Cores that Act in Nucleating Stress Granules Upstream of G3BP1. Current biology : CB 94 31956030
2019 UBAP2L arginine methylation by PRMT1 modulates stress granule assembly. Cell death and differentiation 77 31114027
2000 Low-molecular-weight heparin therapy in percutaneous coronary intervention: the NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators. The Journal of invasive cardiology 33 11156724
2017 UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer. Breast cancer (Tokyo, Japan) 32 29196913
2014 UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity. Blood 32 25185265
2017 Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 23 28334716
2017 Ubiquitin Associated Protein 2-Like (UBAP2L) Overexpression in Patients with Hepatocellular Carcinoma and its Clinical Significance. Medical science monitor : international medical journal of experimental and clinical research 21 28981479
2022 UBAP2L promotes gastric cancer metastasis by activating NF-κB through PI3K/AKT pathway. Cell death discovery 18 35304439
2022 UBAP2/UBAP2L regulate UV-induced ubiquitylation of RNA polymerase II and are the human orthologues of yeast Def1. DNA repair 18 35633597
2024 UBAP2L contributes to formation of P-bodies and modulates their association with stress granules. The Journal of cell biology 17 39007803
2017 UBAP2L is amplified in a large subset of human lung adenocarcinoma and is critical for epithelial lung cell identity and tumor metastasis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 17 28754713
2024 The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactions. EMBO reports 16 38177924
2023 The association of UBAP2L and G3BP1 mediated by small nucleolar RNA is essential for stress granule formation. Communications biology 16 37059803
2018 Upregulation of UBAP2L in Bone Marrow Mesenchymal Stem Cells Promotes Functional Recovery in Rats with Spinal Cord Injury. Current medical science 15 30536073
2022 Ubiquitin Binding Protein 2-Like (UBAP2L): is it so NICE After All? Frontiers in cell and developmental biology 11 35794863
2018 Knockdown of Ubiquitin Associated Protein 2-Like (UBAP2L) Inhibits Growth and Metastasis of Hepatocellular Carcinoma. Medical science monitor : international medical journal of experimental and clinical research 11 30291221
2023 UBAP2L-dependent coupling of PLK1 localization and stability during mitosis. EMBO reports 10 37039032
2020 MicroRNA-19a-3p inhibits the cellular proliferation and invasion of non-small cell lung cancer by downregulating UBAP2L. Experimental and therapeutic medicine 10 32765702
2023 PCK1 activates oncogenic autophagy via down-regulation Serine phosphorylation of UBAP2L and antagonizes colorectal cancer growth. Cancer cell international 9 37062825
2021 Molecular Insights into the Recruiting Between UCP2 and DDX5/UBAP2L in the Metabolic Plasticity of Non-Small-Cell Lung Cancer. Journal of chemical information and modeling 9 34308648
2021 Ubiquitin-associated protein 2 like (UBAP2L) enhances growth and metastasis of gastric cancer cells. Bioengineered 7 34823423
2025 UBAP2L-driven stress granule formation links oxaliplatin resistance to gastric cancer. Communications biology 4 40804300
2024 Whole-exome sequencing identified a novel heterozygous variant in UBAP2L in a Chinese family with neurodevelopmental disorder characterized by impaired language, behavioral abnormalities, and dysmorphic facies. Frontiers in genetics 3 39720179
2021 Norcantharidin-blocked ANXA2P2 inhibits fibroblast proliferation by increasing UBAP2L mRNA stability through LIN28B. Life sciences 3 34043991
2025 O-GlcNAcylation of UBAP2L regulates stress granule formation and sunitinib resistance in clear cell renal cell carcinoma. Journal of experimental & clinical cancer research : CR 2 41029457
2024 UBAP2L ensures homeostasis of nuclear pore complexes at the intact nuclear envelope. The Journal of cell biology 2 38652117
2025 Cold aerobic exercise mitigates NAFLD fibrosis through UBAP2L-regulated TGF-β/SMAD2 signaling. The Journal of endocrinology 1 40163653
2022 WITHDRAWN: LncRNA USP1 Knockdown Weakens the Progression of Colorectal Cancer via Modulating UBAP2L-Smad7-TGF-β Pathway. Combinatorial chemistry & high throughput screening 1 35579161
2021 Analysis of the mTOR Interactome using SILAC technology revealed NICE-4 as a novel regulator of mTORC1 activity. Life sciences 1 34171383
2021 Heritable Variants in the Chromosome 1q22 Locus Increase Gastric Cancer Risk via Altered Chromatin Looping and Increased UBAP2L Expression. Molecular cancer research : MCR 1 34535561
2025 Depletion of UBAP2L suppresses colorectal cancer cell proliferation and radiotherapy resistance by regulating GPX4. Journal of cancer research and clinical oncology 0 40665007
2022 [Retracted] MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L. Experimental and therapeutic medicine 0 36160892